Stocks and Investing
Stocks and Investing
Thu, December 3, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Konstantinos Aprilakis Initiated (STRO) at Strong Buy and Held Target at $25 on, Dec 3rd, 2020
Konstantinos Aprilakis of Stifel, Initiated "Sutro Biopharma, Inc." (STRO) at Strong Buy and Held Target at $25 on, Dec 3rd, 2020.
Konstantinos has made no other calls on STRO in the last 4 months.
There is 1 other peer that has a rating on STRO. Out of the 1 peers that are also analyzing STRO, 0 agree with Konstantinos's Rating of Hold.
This is the rating of the analyst that currently disagrees with Konstantinos
- Roger Song of "Jefferies" Initiated at Strong Buy and Held Target at $21 on, Wednesday, September 2nd, 2020
Contributing Sources